- Consumer Products
- Latest 156.56
- Currency US$
- Change -0.05
- Percent Change -0.032 %
- Volume 5,853,936
- Fri Mar 7, 2014 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jan 30||$1.39||Apr 24||$1.43|
12 months ended Mar 08, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.